Recce Pharmaceuticals Ltd (ASX:RCE)
Australia flag Australia · Delayed Price · Currency is AUD
0.540
0.00 (0.00%)
Apr 28, 2026, 4:10 PM AEST

Recce Pharmaceuticals Market Cap

Recce Pharmaceuticals has a market cap or net worth of 156.16 million as of April 28, 2026. Its market cap has increased by 132.23% in one year.

Market Cap
156.16M
Enterprise Value
156.60M
Revenue
974.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54

Market Cap Chart

Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 156.16M, an increase of 659.99%. That is a compound annual growth rate of 21.79%.

History

DateMarket Cap% Change
Apr 27, 2026156.16M-16.92%
Dec 31, 2025187.97M67.15%
Dec 31, 2024112.46M3.19%
Dec 29, 2023108.98M-7.28%
Dec 30, 2022117.53M-34.34%
Dec 31, 2021179.00M-2.33%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Actinogen Medical 158.03M
Island Pharmaceuticals 110.84M
Alterity Therapeutics 108.75M
Immutep 103.16M
Dimerix 228.15M
Paradigm Biopharmaceuticals 101.65M
Orthocell 236.04M
Tetratherix 240.12M
Market Cap Rankings